Financhill
Sell
28

GRCE Quote, Financials, Valuation and Earnings

Last price:
$2.37
Seasonality move :
-1.52%
Day range:
$2.16 - $2.29
52-week range:
$2.07 - $4.97
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.60x
Volume:
33.4K
Avg. volume:
91.3K
1-year change:
-32.25%
Market cap:
$31.4M
Revenue:
--
EPS (TTM):
-$1.54

Earnings Data

Next earnings date for GRCE
Jun 20
2025
Most recent earnings per share
-$0.36
Missed by $0.04
(Feb 13/2025)
Consensus Estimate
-$0.32
(Feb 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

GRCE Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/20/2025 Q1 -- -- -- -$0.24 --
02/13/2025 Q4 -- -- -$0.36 -$0.32 -$0.04
11/13/2024 Q3 -- -- -$0.30 -$0.36 $0.06
08/09/2024 Q2 -- -- -$0.24 -$0.26 $0.02
03/31/2024 Q1 -- -- -$0.64 -$0.35 -$0.29
12/31/2023 Q4 -- -- -$0.32 -$0.23 -$0.09
09/30/2023 Q3 -- -- -$0.43 -$0.26 -$0.17
06/30/2023 Q2 -- -- -$0.54 -$0.28 -$0.26
03/31/2023 Q1 -- -- -$3.91 -$0.83 -$3.08
12/31/2022 Q4 -- -- -$0.52 -$0.75 $0.23
09/30/2022 Q3 -- -- -$0.66 -- --
06/30/2022 Q2 -- -- -$0.61 -- --
03/31/2022 Q1 -- -- -$0.53 -- --
12/31/2021 Q4 -- -- -$0.54 -- --
09/30/2021 Q3 -- -- $0.18 -- --
06/30/2021 Q2 -- -- -$0.72 -- --
03/31/2021 Q1 -- -- -$1.30 -- --
12/31/2020 Q4 -- -- -$1.56 -- --
09/30/2020 Q3 -- -- -$3.12 -- --
06/30/2020 Q2 -- -- -$2.40 -- --
03/31/2020 Q1 -- -- $10.08 -- --
12/31/2019 Q4 -- -- -$6.72 -- --
09/30/2019 Q3 -- -- -$12.00 -- --
06/30/2019 Q2 -- -- -$5.28 -- --
03/31/2019 Q1 -- -- -$8.61 -- --
12/31/2018 Q4 -- -- -$2.47 -- --
09/30/2018 Q3 -- -- -$23.03 -- --
06/30/2018 Q2 -- -- -$8.39 -- --
03/31/2018 Q1 -- -- -$11.36 -- --
12/31/2017 Q4 -- -- -$15.27 -- --
09/30/2017 Q3 -- -- -$11.99 -- --
06/30/2017 Q2 -- -- -$7.01 -- --
11/30/2016 Q4 -- -- -$7.86 -- --
08/31/2016 Q3 -- -- -$8.07 -- --
05/31/2016 Q2 -- -- -$10.67 -- --
02/29/2016 Q1 -- -- -$6.18 -- --
11/30/2015 Q4 -- -- -$7.54 -- --
08/31/2015 Q3 -- -- -$4.35 -- --
05/31/2015 Q2 -- -- -$3.48 -- --

Grace Therapeutics Earnings Questions

  • How Much did Grace Therapeutics Generate in Revenue Last Quarter?

    Grace Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Grace Therapeutics Beat Earnings Last Quarter?

    Grace Therapeutics announced earnings per share of -$0.36 which represents a miss of analyst forecast a -$0.32 per share.

  • Is Grace Therapeutics Profitable?

    Grace Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Grace Therapeutics EPS Next Year?

    Grace Therapeutics's earnings are forecast to decrease from -$1.73 per share to -$1.44 per share next year representing a decrease of -28.63%.

  • When is Grace Therapeutics's Earnings Date?

    Grace Therapeutics's next earnings date is June 20, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock